RNA interference mediated inhibition of Aurorakinase B and its combinations as anticancer therapy

Details for Australian Patent Application No. 2007298506 (hide)

Owner Reliance Life Sciences Pvt Ltd

Inventors Murali Krishna, Addepalli; Eswar Chandra, Vidyadhar Reddy Gopavaram

Agent Allens Arthur Robinson

Pub. Number AU-B-2007298506

PCT Pub. Number WO2008/035365

Priority 974/MUM/2006 21.06.06 IN

Filing date 21 June 2007

Wipo publication date 27 March 2008

Acceptance publication date 5 April 2012

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/035365 Priority application(s): WO2008/035365

5 April 2012 Application Accepted

  Published as AU-B-2007298506

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007298508-Process for the synthesis of ibandronate sodium

2007298494-Antigen specific multi epitope vaccines